Medical Device Hydrogels
Carboxymethyl Cellulose Platform
New medical devices based on Carboxymethylcellulose Crosslinkata for tissue augmentation, constitute today one absolute innovation on the world market. The potential benefits in terms of costs, production, performance and development, will bring Crosslinkata to carboxymethyl cellulose compete with other medical absorbable devices on the market. Carboxymethyl cellulose, could become the new starting point for the development of new devices used in other applications for medical use.
Hyaluronic Acid Platform
Hyaluronic acid is currently the gold standard in the
context of implantable medical devices, which are used in specialized
areas of medicine. Bioitech is developing a procedure for the use of hyaluronic
acid crosslinkato in ophthalmological and aesthetic context.
Medical Device Components
Started the production of Plunger Rod for syringes used for dermal filler with the purpose of improving handling of Erelle ™.
In the final phase the study which allowed pulverize crosslinked hyaluronic acid with cross-linking degrees overlapping with those used for filler for aesthetic use.
Key Business Areas
© 2012, BIOITECH S.r.l. All right reserved | C.F. e P.I. 10671701000 | Via Chiana, 87 00198 - Roma (Italy)
|Site Map | Legal|